To extend for 10 years the patent for the drug Ethiofos (WR2721) and its oral analogue.

Directs the Secretary of Commerce to extend, upon its expiration, a certain numbered patent for a period of ten years.

 
HR 1314 IH
V
102d CONGRESS
1st Session
 H. R. 1314
To extend for 10 years the patent for the drug Ethiofos (WR2721) and its
oral analogue.
IN THE HOUSE OF REPRESENTATIVES
March 6, 1991
Mr. SYNAR (by request) introduced the following bill; which was referred to
the Committee on the Judiciary
A BILL
To extend for 10 years the patent for the drug Ethiofos (WR2721) and its
oral analogue.
  Be it enacted by the Senate and House of Representatives of the United
  States of America in Congress assembled, That the Secretary of Commerce,
  acting through the Commissioner of Patents shall, when United States Patent
  Number 3,892,824 (relating to the drugs S-2-(3-aminopropylamino) ethyl
  dihydrogen phosphorothioate (Ethiofos) and S-3-(3-methylaminopropylamino)
  propyl dihydrogen phosphorothioate, including hydrates and alkali metal
  salts thereof) expires, or as soon thereafter as possible, extend such
  patent for ten years, with all the rights pertaining thereto.